검색어 : 통합검색[Innes Laura]
총 124건 중 124건 출력
, 7/13 페이지
-
61
- Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
- Alton, Eric W F W; Beekman, Jeffery M; Boyd, A Christopher; Brand, June; Carlon, Marianne S; Connolly, Mary M; Chan, Mario; Conlon, Sinead; Davidson, Heather E; Davies, Jane C; Davies, Lee A; Dekkers, Johanna F; Doherty, Ann; Gea-Sorli, Sabrina; Gill, Deborah R; Griesenbach, Uta; Hasegawa, Mamoru; Higgins, Tracy E; Hironaka, Takashi; Hyndman, Laura; McLachlan, Gerry; Inoue, Makoto; Hyde, Stephen C; Innes, J Alastair; Maher, Toby M; Moran, Caroline; Meng, Cuixiang; Paul-Smith, Michael C; Pringle, Ian A; Pytel, Kamila M; Rodriguez-Martinez, Andrea; Schmidt, Alexander C; Stevenson, Barbara J; Sumner-Jones, Stephanie G; Toshner, Richard; Tsugumine, Shu; Wasowicz, Marguerite W; Zhu, Jie; Department of Gene Therapy , National Heart and Lung Institute, Imperial College London , London , UK; Department of Pediatric Pulmonology, Laboratory of Translational Immunology , Wilhelmina Children's Hospital, University Medical Centre , Utrecht , The Netherlands; Centre for Genomic and Experimental Medicine, IGMM, University of Edinburgh , Edinburgh , UK; Centre for Genomic and Experimental Medicine, IGMM, University of Edinburgh , Edinburgh , UK; Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven , Brussels , Belgium; UK Cystic Fibrosis Gene Therapy Consortium , Oxford , UK; Department of Gene Therapy , National Heart and Lung Institute, Imperial College London , London , UK; Department of Gene Therapy , National Heart and Lung I; (Thorax, v.72, 2017, pp.137-147)
-
62
- Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders
- Stolz, Jacob R.; Foote, Kendall M.; Veenstra-Knol, Hermine E.; Pfundt, Rolph; ten Broeke, Sanne W.; de Leeuw, Nicole; Roht, Laura; Pajusalu, Sander; Part, Reelika; Rebane, Ionella; Õ unap, Katrin; Stark, Zornitza; Kirk, Edwin P.; Lawson, John A.; Lunke, Sebastian; Christodoulou, John; Louie, Raymond J.; Rogers, R. Curtis; Davis, Jessica M.; Innes, A. Micheil; Wei, Xing-Chang; Keren, Boris; Mignot, Cyril; Lebel, Robert Roger; Sperber, Steven M.; Sakonju, Ai; Dosa, Nienke; Barge-Schaapveld, Daniela Q.C.M.; Peeters-Scholte, Cacha M.P.C.D.; Ruivenkamp, Claudia A.L.; van Bon, Bregje W.; Kennedy, Joanna; Low, Karen J.; Ellard, Sian; Pang, Lewis; Junewick, Joseph J.; Mark, Paul R.; Carvill, Gemma L.; Swanson, Geoffrey T.; ; (American journal of human genetics, v.108, 2021, pp.2206)
-
63
- <i>Bacillus subtilis</i> YxaG is a novel Fe-containing quercetin 2,3-dioxygenase
- Bowater, Laura; Fairhurst, Shirley A; Just, Victoria J; Bornemann, Stephen; Biological Chemistry Department, John Innes Centre, Norwich Research Park, Colney, Norwich NR4 7UH, UK; Biological Chemistry Department, John Innes Centre, Norwich Research Park, Colney, Norwich NR4 7UH, UK; Biological Chemistry Department, John Innes Centre, Norwich Research Park, Colney, Norwich NR4 7UH, UK; Corresponding author. Fax: (44)-1603-450018; (FEBS letters, v.557, 2004, pp.45-48)
-
64
- Anthea Innes, Fiona Kelly, and Louise McCabe, Eds. Key Issues in Evolving Dementia Care: International Theory-Based Policy and Practice. Philadelphia, PA: Jessica Kingsley Publishers, 2012.
- Booi, Laura; ; (Canadian journal on aging = La revue canadienne du vieillissement, v.33, 2014, pp.100-102)
-
65
- Repeated nebulisation of non-viral <i>CFTR</i> gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- Alton, Eric W F W; Armstrong, David K; Ashby, Deborah; Bayfield, Katie J; Bilton, Diana; Bloomfield, Emily V; Boyd, A Christopher; Brand, June; Buchan, Ruaridh; Calcedo, Roberto; Carvelli, Paula; Chan, Mario; Cheng, Seng H; Collie, D David S; Cunningham, Steve; Davidson, Heather E; Davies, Gwyneth; Davies, Jane C; Davies, Lee A; Dewar, Maria H; Doherty, Ann; Donovan, Jackie; Dwyer, Natalie S; Elgmati, Hala I; Featherstone, Rosanna F; Gavino, Jemyr; Gea-Sorli, Sabrina; Geddes, Duncan M; Gibson, James S R; Gill, Deborah R; Greening, Andrew P; Griesenbach, Uta; Hansell, David M; Harman, Katharine; Higgins, Tracy E; Hodges, Samantha L; Hyde, Stephen C; Hyndman, Laura; Innes, J Alastair; Jacob, Joseph; Jones, Nancy; Keogh, Brian F; Limberis, Maria P; Lloyd-Evans, Paul; Maclean, Alan W; Manvell, Michelle C; McCormick, Dominique; McGovern, Michael; McLachlan, Gerry; Meng, Cuixiang; Montero, M Angeles; Milligan, Hazel; Moyce, Laura J; Murray; Imperial College London, London, UK; Royal Hospital for Sick Children, Edinburgh, UK; Imperial College London, London, UK; Imperial College London, London, UK; Royal Brompton and Harefield NHS Foundation Trust, London, UK; Imperial College London, London, UK; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK; Western General Hospital, Edinburgh, UK; Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Imperial College London, London, UK; Imperial College London, London, UK; Genzyme, a Sanofi Company, Framingham, MA, USA; The Roslin Institute and R(D)SVS, University of Edinburgh, Edinburgh, UK; Royal Hospital for Sick Children, Edinburgh, UK; Centre for Genomic and Experimental Medicine, Institu; (The Lancet. Respiratory medicine, v.3, 2015, pp.684-691)
-
66
- A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
- Alton, Eric WFW; Armstrong, David K; Ashby, Deborah; Bayfield, Katie J; Bilton, Diana; Bloomfield, Emily V; Boyd, A Christopher; Brand, June; Buchan, Ruaridh; Calcedo, Roberto; Carvelli, Paula; Chan, Mario; Cheng, Seng H; Collie, David S; Cunningham, Steve; Davidson, Heather E; Davies, Gwyneth; Davies, Jane C; Davies, Lee A; Dewar, Maria H; Doherty, Ann; Donovan, Jackie; Dwyer, Natalie S; Elgmati, Hala I; Featherstone, Rosanna F; Gavino, Jemyr; Gea-Sorli, Sabrina; Geddes, Duncan M; Gibson, James SR; Gill, Deborah R; Greening, Andrew P; Griesenbach, Uta; Hansell, David M; Harman, Katharine; Higgins, Tracy E; Hodges, Samantha L; Hyde, Stephen C; Hyndman, Laura; Innes, J Alastair; Jacob, Joseph; Jones, Nancy; Keogh, Brian F; Limberis, Maria P; Lloyd-Evans, Paul; Maclean, Alan W; Manvell, Michelle C; McCormick, Dominique; McGovern, Michael; McLachlan, Gerry; Meng, Cuixiang; Montero, M Angeles; Milligan, Hazel; Moyce, Laura J; Murray, Gor; Department of Gene Therapy, Imperial College London, London, UK; Medical Genetics, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK; Department of Gene Therapy, Imperial College London, London, UK; Department of Gene Therapy, Imperial College London, London, UK; Department of Gene Therapy, Imperial College London, London, UK; Department of Gene Therapy, Imperial College London, London, UK; Medical Genetics, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK; Medical Genetics, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK; Western General Hospital, Edinburgh, UK; Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Gene Therapy, Imperial College London, London, UK; Department of Gene Therapy, Imperial College London, London, UK; Genzyme, a Sanofi Company, Framingham, MA, USA; The Rosli; (Efficacy and mechanism evaluation, v.3, 2016, pp.1-210)
-
67
- The identity of the active site of oxalate decarboxylase and the importance of the stability of active-site lid conformations
- Just, Victoria J.; Burrell, Matthew R.; Bowater, Laura; McRobbie, Iain; Stevenson, Clare E. M.; Lawson, David M.; Bornemann, Stephen; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.; (The Biochemical journal, v.407, 2007, pp.397-406)
-
68
- Multiple Candidate Effectors from the Oomycete Pathogen <i>Hyaloperonospora arabidopsidis</i> Suppress Host Plant Immunity
- Fabro, Georgina; Steinbrenner, Jens; Coates, Mary; Ishaque, Naveed; Baxter, Laura; Studholme, David J.; Kö rner, Evelyn; Allen, Rebecca L.; Piquerez, Sophie J. M.; Rougon-Cardoso, Alejandra; Greenshields, David; Lei, Rita; Badel, Jorge L.; Caillaud, Marie-Cecile; Sohn, Kee-Hoon; Van den Ackerveken, Guido; Parker, Jane E.; Beynon, Jim; Jones, Jonathan D. G.; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; School of Life Sciences, Warwick University, Wellesbourne, United Kingdom; School of Life Sciences, Warwick University, Wellesbourne, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; School of Life Sciences, Warwick University, Wellesbourne, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; School of Life Sciences, Warwick University, Wellesbourne, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, United Kingdom; The Sainsbury Laboratory, John Innes Centre, Norwich, Uni; (PLoS pathogens, v.7, 2011, pp.e1002348)
-
69
- TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations
- O'Rawe, Jason A.; Wu, Y.; Dorfel, Max J.; Rope, Alan F.; Au, P.; Parboosingh, Jillian S.; Moon, S.; Kousi, M.; Kosma, K.; Smith, Christopher S.; Tzetis, M.; Schuette, Jane L.; Hufnagel, Robert B.; Prada, Carlos E.; Martinez, F.; Orellana, C.; Crain, J.; Caro-Llopis, A.; Oltra, S.; Monfort, S.; Jimenez-Barron, Laura T.; Swensen, J.; Ellingwood, S.; Smith, R.; Fang, H.; Ospina, S.; Stegmann, S.; Den Hollander, N.; Mittelman, D.; Highnam, G.; Robison, R.; Yang, E.; Faivre, L.; Roubertie, A.; Riviere, J.B.; Monaghan, Kristin G.; Wang, K.; Davis, Erica E.; Katsanis, N.; Kalscheuer, Vera M.; Wang, Edith H.; Metcalfe, K.; Kleefstra, T.; Innes, A.; Kitsiou-Tzeli, S.; Rosello, M.; Keegan, Catherine E.; Lyon, Gholson J.; ; (American journal of human genetics, v.97, 2015, pp.922-932)
-
70
- Clustered mutations in the <i>GRIK2</i> kainate receptor subunit gene underlie diverse neurodevelopmental disorders
-
Stolz, Jacob R.;
Foote, Kendall M.;
Veenstra-Knol, Hermine E.;
Pfundt, Rolph;
ten Broeke, Sanne W.;
de Leeuw, Nicole;
Roht, Laura;
Pajusalu, Sander;
Part, Reelika;
Rebane, Ionella;
Õ
unap, Katrin;
Stark, Zornitza;
Kirk, Edwin P.;
Lawson, John A.;
Lunke, Sebastian;
Christodoulou, John;
Louie, Raymond J.;
Rogers, R. Curtis;
Davis, Jessica M.;
Innes, A. Micheil;
Wei, Xing-Chang;
Keren, Boris;
Mignot, Cyril;
Lebel, Robert Roger;
Sperber, Steven M.;
Sakonju, Ai;
Dosa, Nienke;
Barge-Schaapveld, Daniela Q.C.M.;
Peeters-Scholte, Cacha M.P.C.D.;
Ruivenkamp, Claudia A.L.;
van Bon, Bregje W.;
Kennedy, Joanna;
Low, Karen J.;
Ellard, Sian;
Pang, Lewis;
Junewick, Joseph J.;
Mark, Paul R.;
Carvill, Gemma L.;
Swanson, Geoffrey T.;
Department of Pharmacology, Feinberg School of Medicine, Northwestern University;
Department of Pharmacology, Feinberg School of Medicine, Northwestern University;
Department of Genetics, University Medical Center Groningen;
Department of Human Genetics, Radboud University Nijmegen Medical Centre;
Department of Genetics, University Medical Center Groningen;
Department of Human Genetics, Radboud University Nijmegen Medical Centre;
Department of Clinical Genetics, Tartu University Hospital;
Department of Clinical Genetics, Tartu University Hospital;
Department of Neonatal and Infant Medicine, Tallinn Children’s Hospital;
Department of Neonatal and Infant Medicine, Tallinn Children’s Hospital
Estonia
QUICK MENU
